Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Biological Features Between pN0 Triple Negative Breast Tumours With Size < or = 10 mm (pT1a/b) Versus pT1c T2 < or = 30 mm.

NCT02266420 is registered in ClinicalTrials.gov with Institut Claudius Regaud as lead sponsor.

NCT NCT02266420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02266420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Biological Features Between pN0 Triple Negative Breast Tumours With Size < or = 10 mm (pT1a/b) Versus pT1c T2 < or = 30 mm.
Lead sponsor
Institut Claudius Regaud
Phase
Not applicable
Overall status
Completed
Start date
October 23, 2014
Completion date
October 29, 2024
Enrollment
151 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

triple negative breast cancers without lymph-node involvement and < or = 30 mm